Terms: = Colorectal cancer AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1 AND Prognosis
3 results:
1. Nuclear export of BATF2 enhances colorectal cancer proliferation through binding to crm1.
Zhou J; Lei Z; Chen J; Liao S; Chen Y; Liu C; Huang S; Li L; Zhang Y; Wang P; Huang Y; Li J; Liang H
Clin Transl Med; 2023 May; 13(5):e1260. PubMed ID: 37151195
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.
Li P; Ou Q; Braciak TA; Chen G; Oduncu FS
Jpn J Clin Oncol; 2018 Jul; 48(7):619-624. PubMed ID: 29529220
[TBL] [Abstract] [Full Text] [Related]
3. First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
Vivaldi C; Caparello C; Musettini G; Pasquini G; Catanese S; Fornaro L; Lencioni M; Falcone A; Vasile E
Int J Cancer; 2016 Aug; 139(4):938-45. PubMed ID: 27038273
[TBL] [Abstract] [Full Text] [Related]
